Bank of Montreal
RXII

Bank of Montreal’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bank of Montreal’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,930
Closed -$5K – 4348
2016
Q3 		$5K Sell
15,930
-85,387
-84% -$26.8K ﹤0.01% 3733
2016
Q2 		$47K Buy
101,317
+99,635
+5,924% +$46.2K ﹤0.01% 3089
2016
Q1 		$2K Sell
1,682
-1,190
-41% -$1.42K ﹤0.01% 4028
2015
Q4 		$4K Buy
2,872
+1,190
+71% +$1.66K ﹤0.01% 3884
2015
Q3 		$3K Sell
1,682
-17,070
-91% -$30.4K ﹤0.01% 3772
2015
Q2 		$32K Buy
18,752
+18,000
+2,394% +$30.7K ﹤0.01% 3157
2015
Q1 		$1K Hold
752
– – ﹤0.01% 3938
2014
Q4 		$1K Buy
+752
New +$1K ﹤0.01% 3994
2014
Q3 		– Sell
-3,050
Closed -$9K – 4922
2014
Q2 		$9K Buy
+3,050
New +$9K ﹤0.01% 3948

Bank of Montreal's RXII Position: Q4 2016 in Review

Bank of Montreal sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 15,930 shares — an estimated $5K sold.

Bank of Montreal first reported a position in RXII in Q2 2014 and held it in 9 quarters. The position peaked at $47K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Bank of Montreal reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Bank of Montreal sold 15,930 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
  • Bank of Montreal first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 9 quarters.
  • Bank of Montreal's GALENA BIOPHARMA INC COM position peaked at $47K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Bank of Montreal's 13F filing for Q4 2016, filed 6 Feb 2017.